Trial intelligence / Profile preview

Povidone-Iodine for Bacterial Corneal Ulcers

NCT00386958Phase 2Completed

Sponsor
The Lundquist Institute
Start
Nov 2002
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of povidone-iodine in bacterial keratitis (4 arms), sponsored by The Lundquist Institute. Primary endpoints: Days to cure and Safety of study medication. Started Nov 2002; status: completed.

02

Drugs

povidone-iodine
03

Conditions

bacterial keratitis

Beyond the preview

Go deeper on NCT00386958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00386958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call